Berotralstat Hydrochloride
Brand name: Orladeyo
Rank #476 of 500 drugs by total cost
$15.1M
Total Cost
374
Total Claims
$15.1M
Total Cost
27
Prescribers
$40K
Cost per Claim
0
Beneficiaries
374
30-Day Fills
$557K
Avg Cost/Provider
14
Avg Claims/Provider
About Berotralstat Hydrochloride
Berotralstat Hydrochloride (sold as Orladeyo) was prescribed 374 times by 27 Medicare Part D providers in 2023, costing the program $15.1M. At $40K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 473 | Fluocinonide (Fluocinonide) | $15.3M | 217,528 |
| 474 | Diclofenac Potassium (Diclofenac Potassium) | $15.2M | 96,736 |
| 475 | Capmatinib Hydrochloride (Tabrecta) | $15.1M | 824 |
| 476 | Berotralstat Hydrochloride (Orladeyo) | $15.1M | 374 |
| 477 | Lansoprazole (Lansoprazole) | $15.0M | 309,355 |
| 478 | Raloxifene Hcl (Raloxifene Hcl) | $14.8M | 198,063 |
| 479 | Lanthanum Carbonate (Lanthanum Carbonate) | $14.7M | 13,783 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology